Log in to save to my catalogue
Log in to save to my catalogue

First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 g...

| Ask | Become a Library member

First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 g...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_882534

First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial

About this item

Full title

First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial

Author / Creator

Rydelius, Johanna , Hognert, Helena , Kopp-Kallner, Helena , Brandell, Karin , Romell, Joanna , Zetterström, Karin , Teleman, Pia , Gemzell-Danielsson, Kristina , Faculty of Medicine , Department of Clinical Sciences, Lund , Obstetrics and Gynaecology (Lund) , Medicinska fakulteten , Lund University , Sektion V , Obstetrik och gynekologi, Lund , Section V , Institutionen för kliniska vetenskaper, Lund and Lunds universitet

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2024-08, Vol.404 (10455), p.864-873

Language

English

Formats

Articles

Publication information

Publisher

England: Elsevier Ltd

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Medical abortion after 12 gestational weeks often requires a stay in hospital. We hypothesised that administering the first misoprostol dose at home could increase day-care procedures as compared with overnight care procedures, shorten inpatient stays, and improve patient satisfaction.
This multicentre, open-label, randomised controlled trial wa...

Alternative Titles

Full title

First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_882534

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_882534

Other Identifiers

ISSN

0140-6736,1474-547X

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(24)01079-1

How to access this item

Log in as a Library member

Full text available

About resource

About resource

About resource

About resource

ERROR: Invalid URL specified.

About resource

View in old catalogue

Connecting people and collections